Atricure, Inc. (ATRC) Reports In-Line Q4 EPS, Offer FY15 Guidance
Get Alerts ATRC Hot Sheet
Price: $48.98 +3.14%
Financial Fact:
Loss from operations: -6.29M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Loss from operations: -6.29M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Atricure, Inc. (NASDAQ: ATRC) reported Q4 EPS of ($0.20), in-line with the analyst estimate of ($0.20). Revenue for the quarter came in at $29.4 million versus the consensus estimate of $28.4 million.
Atricure, Inc. sees FY2015 revenue of $122.5-124.5 million, versus the consensus of $122.43 million.
Adjusted EBITDA, a non-GAAP measure, is projected to be a loss in the range of $7 million to $9 million for 2015 as we continue to make strategic investments to drive our long-term growth plan.
For earnings history and earnings-related data on Atricure, Inc. (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'
- S&P 500 may pull back before midterms, but Citi says buy the dip
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share